Hypoxia may sustain radioresistance of gliomas, and therefore targeting tumor hypoxia by inhibiting HIF-1α could enhance the radiosensitivity of human malignant gliomas and subsequently improve the radiotherapy outcomes [33, 34]. Here, HIF1A is linked to neoplasm.